{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:39:13Z","timestamp":1792622353868,"version":"4.5.0"},"reference-count":28,"publisher":"MyJove Corporation","issue":"168","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/62128","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T19:02:56Z","timestamp":1613674976000},"source":"Crossref","is-referenced-by-count":6,"title":["Stereotaxic Intracranial Delivery of Chemicals, Proteins or Viral Vectors to Study Parkinson's Disease"],"prefix":"10.3791","author":[{"given":"Natalie","family":"Landeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Conti Mazza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Duffy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bishop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caryl E.","family":"Sortwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Cookson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2021,2,18]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0733-8619(05)70259-0","type":"journal-article","article-title":"Epidemiology of Parkinson's disease","volume":"14","author":"Tanner","year":"1996","unstructured":"Tanner, C.M., Goldman, S.M. Epidemiology of Parkinson's disease. Neurologic Clinics. 14 (2), 317-335, (1996).","journal-title":"Neurologic Clinics"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/jnnp.54.2.159","type":"journal-article","article-title":"Diffuse Lewy body disease presenting with a supranuclear gaze palsy","volume":"54","author":"Fearnley","year":"1991","unstructured":"Fearnley, J.M., Revesz, T., Brooks, D.J., Frackowiak, R.S., Lees, A.J. Diffuse Lewy body disease presenting with a supranuclear gaze palsy. Journal of Neurology, Neurosurgery & Psychiatry. 54 (2), 159, (1991).","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/brain\/awt192","type":"journal-article","article-title":"Disease duration and the integrity of the nigrostriatal system in Parkinson's disease","volume":"136","author":"Kordower","year":"2013","unstructured":"Kordower, J.H. et al. Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. Brain. 136 (8), 2419-2431, (2013).","journal-title":"Brain"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0304-3940(99)00208-6","type":"journal-article","article-title":"Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by \u03b1-synuclein immunocytochemistry","volume":"265","author":"Braak","year":"1999","unstructured":"Braak, H., Sandmann-Keil, D., Gai, W., Braak, E. Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by \u03b1-synuclein immunocytochemistry. Neuroscience Letters. 265 (1), 67-69, (1999).","journal-title":"Neuroscience Letters"},{"issue":"6645","key":"ref5","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","type":"journal-article","article-title":"\u03b1-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","unstructured":"Spillantini, M.G., Schmidt, M.L., Lee, V.M.Y., Trojanowski, J.Q., Jakes, R., Goedert, M. \u03b1-Synuclein in Lewy bodies. Nature. 388 (6645), 839-840, (1997).","journal-title":"Nature"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/hmg\/ddm159","type":"journal-article","article-title":"Parkinson's disease","volume":"16","author":"Thomas","year":"2007","unstructured":"Thomas, B., Beal, M.F. Parkinson's disease. Human Molecular Genetics. 16 (R2), R183-R194, (2007).","journal-title":"Human Molecular Genetics"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/bs.pbr.2020.02.003","type":"journal-article","article-title":"Animal models for preclinical Parkinson's research: An update and critical appraisal","volume":"252","author":"Cenci","year":"2020","unstructured":"Cenci, M.A., Bj\u00f6rklund, A. Animal models for preclinical Parkinson's research: An update and critical appraisal. Progress in Brain Research. 252, 27-59, (2020).","journal-title":"Progress in Brain Research"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1602\/neurorx.2.3.484","type":"journal-article","article-title":"Toxin-induced models of Parkinson's disease","volume":"2","author":"Bov\u00e9","year":"2005","unstructured":"Bov\u00e9, J., Prou, D., Perier, C., Przedborski, S. Toxin-induced models of Parkinson's disease. NeuroRX. 2 (3), 484-494, (2005).","journal-title":"NeuroRX"},{"issue":"7669","key":"ref9","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nature23664","type":"journal-article","article-title":"Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model","volume":"548","author":"Kikuchi","year":"2017","unstructured":"Kikuchi, T. et al. Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model. Nature. 548 (7669), 592-596, (2017).","journal-title":"Nature"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.toxlet.2014.01.039","type":"journal-article","article-title":"Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases-A mechanistic approach","volume":"230","author":"Baltazar","year":"2014","unstructured":"Baltazar, M.T., Dinis-Oliveira, R.J., Bastos, M. de L., Tsatsakis, A.M., Duarte, J.A., Carvalho, F. Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases-A mechanistic approach. Toxicology Letters. 230 (2), 85-103, (2014).","journal-title":"Toxicology Letters"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/ejn.14300","type":"journal-article","article-title":"Genetically engineered animal models of Parkinson's disease: From worm to rodent","volume":"49","author":"Breger","year":"2019","unstructured":"Breger, L.S., Armentero, M.T.F. Genetically engineered animal models of Parkinson's disease: From worm to rodent. European Journal of Neuroscience. 49 (4), 533-560, (2019).","journal-title":"European Journal of Neuroscience"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00401-014-1256-4","type":"journal-article","article-title":"Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials","volume":"127","author":"Mandler","year":"2014","unstructured":"Mandler, M. et al. Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials. Acta Neuropathologica. 127 (6), 861-879, (2014).","journal-title":"Acta Neuropathologica"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.nbd.2011.12.038","type":"journal-article","article-title":"Use of viral vectors to create animal models for Parkinson's disease","volume":"48","author":"L\u00f6w","year":"2012","unstructured":"L\u00f6w, K., Aebischer, P. Use of viral vectors to create animal models for Parkinson's disease. Neurobiology of Disease. 48 (2), 189-201, (2012).","journal-title":"Neurobiology of Disease"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","type":"journal-article","article-title":"Parkinson-Like Neurodegeneration Induced by Targeted Overexpression of \u03b1-Synuclein in the Nigrostriatal System","volume":"22","author":"Kirik","year":"2002","unstructured":"Kirik, D. et al. Parkinson-Like Neurodegeneration Induced by Targeted Overexpression of \u03b1-Synuclein in the Nigrostriatal System. Journal of Neuroscience. 22 (7), 2780-2791, (2002).","journal-title":"Journal of Neuroscience"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20112457","type":"journal-article","article-title":"Intracerebral inoculation of pathological \u03b1-synuclein initiates a rapidly progressive neurodegenerative \u03b1-synucleinopathy in miceSpread of pathological \u03b1-synuclein in vivo","volume":"209","author":"Luk","year":"2012","unstructured":"Luk, K.C., Kehm, V.M., Zhang, B., O'Brien, P., Trojanowski, J.Q., Lee, V.M.Y. Intracerebral inoculation of pathological \u03b1-synuclein initiates a rapidly progressive neurodegenerative \u03b1-synucleinopathy in miceSpread of pathological \u03b1-synuclein in vivo. The Journal of Experimental Medicine. 209 (5), 975-986, (2012).","journal-title":"The Journal of Experimental Medicine"},{"issue":"6109","key":"ref16","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","type":"journal-article","article-title":"Pathological \u03b1-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice","volume":"338","author":"Luk","year":"2012","unstructured":"Luk, K.C. et al. Pathological \u03b1-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice. Science. 338 (6109), 949-953, (2012).","journal-title":"Science"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"104712","DOI":"10.1016\/j.nbd.2019.104712","type":"journal-article","article-title":"Characterization of novel conformation-selective \u03b1-synuclein antibodies as potential immunotherapeutic agents for Parkinson's disease","volume":"136","author":"Henderson","year":"2019","unstructured":"Henderson, M.X. et al. Characterization of novel conformation-selective \u03b1-synuclein antibodies as potential immunotherapeutic agents for Parkinson's disease. Neurobiology of Disease. 136, 104712, (2019).","journal-title":"Neurobiology of Disease"},{"issue":"26","key":"ref18","doi-asserted-by":"crossref","first-page":"15209","DOI":"10.1073\/pnas.2001305117","type":"journal-article","article-title":"Impact of \u03b1-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized \u03b1-synuclein rat model of PD","volume":"117","author":"Hoban","year":"2020","unstructured":"Hoban, D.B. et al. Impact of \u03b1-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized \u03b1-synuclein rat model of PD. Proceedings of the National Academy of Sciences. 117 (26), 15209-15220, (2020).","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"39","key":"ref19","doi-asserted-by":"crossref","first-page":"8284","DOI":"10.1073\/pnas.1710442114","type":"journal-article","article-title":"Modeling Parkinson's disease pathology by combination of fibril seeds and \u03b1-synuclein overexpression in the rat brain","volume":"114","author":"Thakur","year":"2017","unstructured":"Thakur, P. et al. Modeling Parkinson's disease pathology by combination of fibril seeds and \u03b1-synuclein overexpression in the rat brain. Proceedings of the National Academy of Sciences. 114 (39), E8284-E8293, (2017).","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/brain\/awp314","type":"journal-article","article-title":"Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson's disease","volume":"133","author":"Bj\u00f6rklund","year":"2010","unstructured":"Bj\u00f6rklund, T., Carlsson, T., Cederfj\u00e4ll, E.A., Carta, M., Kirik, D. Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson's disease. Brain. 133 (2), 496-511, (2010).","journal-title":"Brain"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12974-018-1171-z","type":"journal-article","article-title":"Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration","volume":"15","author":"Duffy","year":"2018","unstructured":"Duffy, M.F. et al. Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration. Journal of Neuroinflammation. 15 (1), 129, (2018).","journal-title":"Journal of Neuroinflammation"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-7091-6842-4_7","type":"journal-article","article-title":"Mechanism of 6-hydroxydopamine neurotoxicity","volume":"50","author":"Glinka","year":"1997","unstructured":"Glinka, Y., Gassen, M., Youdim, M.B.H. Mechanism of 6-hydroxydopamine neurotoxicity. Journal of neural transmission. Supplementum. 50, 55-66, (1997).","journal-title":"Journal of neural transmission. Supplementum"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3233\/JPD-2011-11023","type":"journal-article","article-title":"MPTP mouse models of Parkinson's disease: an update","volume":"1","author":"Meredith","year":"2011","unstructured":"Meredith, G.E., Rademacher, D.J. MPTP mouse models of Parkinson's disease: an update. Journal of Parkinson's disease. 1 (1), 19-33, (2011).","journal-title":"Journal of Parkinson's disease"},{"key":"ref24","type":"journal-article","article-title":"Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors","volume":"143","author":"Fripont","year":"2019","unstructured":"Fripont, S., Marneffe, C., Marino, M., Rincon, M.Y., Holt, M.G. Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors. Journal of Visualized Experiments. 143, (2019).","journal-title":"Journal of Visualized Experiments"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/ejn.13493","type":"journal-article","article-title":"Toxic effects of human and rodent variants of alpha-synuclein in vivo","volume":"45","author":"Landeck","year":"2017","unstructured":"Landeck, N., Buck, K., Kirik, D. Toxic effects of human and rodent variants of alpha-synuclein in vivo. European Journal of Neuroscience. 45 (4), 536-547, (2017).","journal-title":"European Journal of Neuroscience"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3233\/JPD-171248","type":"journal-article","article-title":"Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson's Disease in Rodents","volume":"8","author":"Polinski","year":"2018","unstructured":"Polinski, N.K. et al. Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson's Disease in Rodents. Journal of Parkinson's Disease. 8(2), 303-322, (2018).","journal-title":"Journal of Parkinson's Disease"},{"key":"ref27","type":"journal-article","article-title":"Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo","volume":"148","author":"Patterson","year":"2019","unstructured":"Patterson, J.R. et al. Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo. Journal of Visualized Experiments. 148, (2019).","journal-title":"Journal of Visualized Experiments"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.nbd.2015.06.003","type":"journal-article","article-title":"Intrastriatal injection of pre-formed mouse \u03b1-synuclein fibrils into rats triggers \u03b1-synuclein pathology and bilateral nigrostriatal degeneration","volume":"82","author":"Paumier","year":"2015","unstructured":"Paumier, K.L. et al. Intrastriatal injection of pre-formed mouse \u03b1-synuclein fibrils into rats triggers \u03b1-synuclein pathology and bilateral nigrostriatal degeneration. Neurobiology of Disease. 82, 185-199, (2015).","journal-title":"Neurobiology of Disease"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/62128\/stereotaxic-intracranial-delivery-chemicals-proteins-or-viral-vectors","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:00:16Z","timestamp":1792620016000},"score":1,"resource":{"primary":{"URL":"https:\/\/app.jove.com\/t\/62128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,18]]},"references-count":28,"journal-issue":{"issue":"168","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.3791\/62128","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,18]]}}}